Click on headlines below to download research

AGM produces key highlights
Sareum Holdings | 17/12/2021

Sareum’s annual general meeting (AGM) on 16 December provided key updates on its upcoming business plans. Final toxicology and safety studies for…

SDC-1801’s clinical plan modified
Sareum Holdings | 23/11/2021

Sareum’s lead asset SDC-1801 is inching closer to completing its preclinical toxicology studies, although the decision to pursue a capsule alternative…

Fund raising to cushion pipeline risk
Sareum Holdings | 20/08/2021

Sareum released a trading update on 19 August ahead of its full-year results (financial year end 30 June 2021) expected in October 2021. Final pre-clinical…